Lymphoma

Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman

inVentiv adds new comms exec; Julie Bowen teams up with Mylan for allergy emergencies; Royalty raises the bid on Elan; Pfizer nixes non-Hodgkin's lymphoma drug in trials.

Business briefs: Eli Lilly, Millennium/Takeda, Elan

Eli Lilly nixes one trial and fails another; Millennium is folded into Takeda, Dunsire retires; Elan pays for Theravance royalties in attempt to avoid takeover.

Email Newsletters